FFCP PHASE1:Mm9::chr2:178240765..178240774,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr2:178240765..178240774,-|id=chr2:178240765..178240774,-|ontology_enrichment_celltype=CL:0000355!4.34e-08!9|ontology_enrichment_celltype_v019_2=CL:0000355,1.30e-11,9|ontology_enrichment_disease=DOID:0060100!4.72e-23!3;DOID:4045!4.72e-23!3;DOID:0050686!7.42e-12!6|ontology_enrichment_disease_v019_2=DOID:0060100,2.80e-33,3;DOID:4045,2.80e-33,3;DOID:0050686,4.67e-17,6|ontology_enrichment_uberon=UBERON:0001134!4.34e-08!9;UBERON:0002036!4.34e-08!9;UBERON:0002385!4.34e-08!9;UBERON:0000486!4.34e-08!9;UBERON:0001015!4.34e-08!9;UBERON:0004290!4.34e-08!9;UBERON:0003082!4.34e-08!9;UBERON:0000383!2.49e-07!10|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.30e-11,9;UBERON:0002036,1.30e-11,9;UBERON:0002385,1.30e-11,9;UBERON:0000486,1.30e-11,9;UBERON:0007503,1.30e-11,9;UBERON:0001015,1.30e-11,9;UBERON:0002329,1.30e-11,9;UBERON:0003082,1.30e-11,9;UBERON:0003059,1.30e-11,9;UBERON:0007282,1.30e-11,9;UBERON:0004290,1.30e-11,9;UBERON:0009618,1.30e-11,9;UBERON:0000383,1.61e-10,10;UBERON:0007524,1.27e-09,11;UBERON:0003077,1.27e-09,11;UBERON:0007285,1.27e-09,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.95210098400125,10.9386948233332,1.57057123192139,27.6468799374577,17.7591826089196,4.85510353031154,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.359445373517761,0,0.127070227073065,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.287696137450811,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.18984900995699,1.95932033253121,0.690999869022119,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr2:178240765..178240774,-}} | ||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|description=CAGE_peak_at_chr2:178240765..178240774,- | |||
|id=chr2:178240765..178240774,- | |||
|ontology_enrichment_celltype=CL:0000355!4.34e-08!9 | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,1.30e-11,9 | |||
|ontology_enrichment_disease=DOID:0060100!4.72e-23!3;DOID:4045!4.72e-23!3;DOID:0050686!7.42e-12!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,2.80e-33,3;DOID:4045,2.80e-33,3;DOID:0050686,4.67e-17,6 | |||
|ontology_enrichment_uberon=UBERON:0001134!4.34e-08!9;UBERON:0002036!4.34e-08!9;UBERON:0002385!4.34e-08!9;UBERON:0000486!4.34e-08!9;UBERON:0001015!4.34e-08!9;UBERON:0004290!4.34e-08!9;UBERON:0003082!4.34e-08!9;UBERON:0000383!2.49e-07!10 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.30e-11,9;UBERON:0002036,1.30e-11,9;UBERON:0002385,1.30e-11,9;UBERON:0000486,1.30e-11,9;UBERON:0007503,1.30e-11,9;UBERON:0001015,1.30e-11,9;UBERON:0002329,1.30e-11,9;UBERON:0003082,1.30e-11,9;UBERON:0003059,1.30e-11,9;UBERON:0007282,1.30e-11,9;UBERON:0004290,1.30e-11,9;UBERON:0009618,1.30e-11,9;UBERON:0000383,1.61e-10,10;UBERON:0007524,1.27e-09,11;UBERON:0003077,1.27e-09,11;UBERON:0007285,1.27e-09,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.95210098400125,10.9386948233332,1.57057123192139,27.6468799374577,17.7591826089196,4.85510353031154,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.359445373517761,0,0.127070227073065,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.287696137450811,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.18984900995699,1.95932033253121,0.690999869022119,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr2:178240765..178240774,- | |||
}} |
Revision as of 23:10, 13 September 2013
Short description: | p@chr2:178240765..178240774, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr2:178240765..178240774, - |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 1.30e-11 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 1.30e-11 | 9 |
striated muscle tissue | 1.30e-11 | 9 |
muscle tissue | 1.30e-11 | 9 |
multilaminar epithelium | 1.30e-11 | 9 |
epithelial vesicle | 1.30e-11 | 9 |
musculature | 1.30e-11 | 9 |
somite | 1.30e-11 | 9 |
myotome | 1.30e-11 | 9 |
presomitic mesoderm | 1.30e-11 | 9 |
presumptive segmental plate | 1.30e-11 | 9 |
dermomyotome | 1.30e-11 | 9 |
trunk paraxial mesoderm | 1.30e-11 | 9 |
musculature of body | 1.61e-10 | 10 |
dense mesenchyme tissue | 1.27e-09 | 11 |
paraxial mesoderm | 1.27e-09 | 11 |
presumptive paraxial mesoderm | 1.27e-09 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 2.80e-33 | 3 |
muscle cancer | 2.80e-33 | 3 |
organ system cancer | 4.67e-17 | 6 |
Property "Dpi dataset" (as page type) with input value "{{{DPIdataset}}}" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.
Property "TSS like by RIKEN classifier" (as page type) with input value "{{{TSSclassifier}}}" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.
Property "DHS support" (as page type) with input value "{{{DHSsupport}}}" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.